Genky DrugStores Co., Ltd.

9267.T
Pharmaceutical Retailers
2026/02/17 Updated
Market Cap: $897.0M (¥137.2B)
Stock Price: $29.43 (¥4,500)
Exchange Rate: 1 USD = ¥152.91

Monthly Sales Update for January, Fiscal Year Ending June 2026

For January 2026, total store sales were 105.7% YoY, existing stores 98.6%, with one new store opened, bringing the total number of stores to 500.

Importance:
Page Updated: January 27, 2026
IR Disclosure Date: January 27, 2026

Key Figures

  • Total Store Sales Year-over-Year: 105.7%
  • Existing Store Sales Year-over-Year: 98.6%
  • Total Number of Stores: 500 stores

AI要約

Overview of Monthly Sales Update

According to the monthly sales update for January in the fiscal year ending June 2026, total store sales grew 105.7% YoY, exceeding last year’s performance; however, sales at existing stores were down to 98.6% YoY. Customer traffic at existing stores remained almost flat at 100.1%, while spending per customer declined to 98.5%. One new store was opened, bringing the total number of stores to 500. These figures are provisional based on monthly results and may differ from official financial statements.

Store Expansion and Standardization Initiatives

All new stores opened are standardized regular stores of 300 tsubo, and five stores underwent renovations. Renovations are aimed at standardizing larger stores into regular formats. One store was closed, resulting in a net increase in the number of stores. This suggests a strategy to compensate for declining sales at existing stores by promoting store standardization through new openings and renovations.

Year-over-Year Sales Growth (All Stores) Trend (Jan 2025 - Jan 2026)

Year-over-Year Sales Growth (Existing Stores) Trend (Jan 2025 - Jan 2026)

Year-over-Year Customer Count (Existing Stores) Trend (Jan 2025 - Jan 2026)

Year-over-Year Spending per Customer (Existing Stores) Trend (Jan 2025 - Jan 2026)

Total Number of Stores Trend (Jan 2025 - Jan 2026)

This page uses AI to summarize IR materials from TDnet. Please refer to the original document for investment decisions.